EMA activates plans for health threats to support coronavirus work

The European Medicines Agency (EMA) has activated its plan for managing emerging health threats to support manufacturers of vaccines and treatments for the coronavirus currently causing infections around the world.

EMA has asked that any companies working on vaccines or medicinal products for either the treatment or prevention of the virus, known as 2019-nCoV, reach out to the Agency to discuss their plans.

Guido Rasi, EMA Executive Director, said:

“EMA has activated its plan for managing emerging health threats… The new coronavirus has been declared a public health emergency of international concern by the World Health Organization, and we are drawing on the strong expertise of the European medicines network to provide fast-track scientific advice and give prompt feedback on any proposed medicine developments.”

Find out more here, and contact EMA about plans to develop treatments or vaccines here.

Tagged with

Published on 6. February 2020 in News, News EU, Press Release